Medable: Patient First Solutions For Oncology

66% of oncology trials fold prematurely due to low enrollment. What if we could make it easier for people to participate...

Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting – with a single point of entry for patients, sites and sponsors. Tokenization also streamlines data collection post-trial for lifelong follow-up, connecting patient trial data and real-world data to capture critical endpoints.

The offering helps to improve access to trials and increase retention by enabling patients undergoing intensive cancer therapies to participate both remotely at home and on-site. Timely notifications and reminders help ensure compliance, while real-time reporting functionality enhances patient-(and caregiver)-friendly ePROs, making it easy to track and respond to emerging toxicity and tolerability signals.